Skip to content

Adrenaline V/s Dopamine in Fuid Refractory Septic Shock

Comparison of the Efficacy of Renaline and Dopamine in the Treatment of Fluid Refractory Septic Shock in Children

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07273526
Enrollment
90
Registered
2025-12-09
Start date
2025-06-01
Completion date
2025-12-31
Last updated
2025-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Refractory Septic Shock, Septic Shock

Keywords

Septic Shock, Adrenaine, Dopamine, Fluid refractory septic shock

Brief summary

This study compares the efficacy of two drugs i.e Adrenaline and dopamine in fluid refractory type of septic shock which is a dreadful medical condition especially in children. The efficacy will be checked based on heart rate , GCS, capillary refill time , palpable pripheral pulse , urine output and systolic blood pressure.

Detailed description

This is a randomized control trial in which children / patients diagnosed with Fluid refractory Septic shock will be provided with one of the two drugs ina randomzied way and their efficacy will be assesed on the basis of correction of various parameters at various points of time.

Interventions

DRUGAdrenaline

The adrenaline will be given as a vasoconstrictor in the dose of 0.1-0.3ug/kg/min to the patients in group A when diagnosed with fluid refractory septic shock

DRUGDopamine

The drug dopamine will be adminitered in dose of 10-20ug/kg/min to the patients of group B when diagnosed with fluid refractory septic shock.

Sponsors

Laiba Qamar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 12 Months
Healthy volunteers
No

Inclusion criteria

Patients of both Genders having age range between 1month and 12 years with diagnosis of fluid refractory septic shock as per operational definition. \-

Exclusion criteria

* Patients with 1. cardiopumonary Bypass during last 5 days 2. Chronic Systemic disease like Chronic kidney Disease , cerebral palsy, congenital heart disease 3. neuromuscular discorder 4. Metabolic disorders 5. Those who already had treatment at periphery for hypovolemia without any record of medication or sequential organ failure at presentation

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure6 hoursThe blood pressure of the patients will be meaures after administration of each drug at 20 mins and 6 hours.
Pulse6 hoursThe pulse will be compared after adminitration of both drugs at 20 mins and 6 hours
Capillary Refill Time6 HoursCapillary Refill time will be assessed after administration of each drug at 20 mins and 6 hours
Urine output6 hoursUrine output will be calculated from the time of administration of each drug at 20mins and 6 hours and comapred.
GCS6 hoursGlascow Comma Scale (GCS) will be asses at 20 mins and 6 hours after administration of each drug

Secondary

MeasureTime frameDescription
SOFA ( Sequential Organ Failure Assesment)6 HoursSOFA ( Sequential Organ Failure Assesment) score will be calculated afte adminitration of each drug at 20mins and 6 hours

Countries

Pakistan

Contacts

Primary ContactHafiz Muhammad Abdullah Dr, MBBS
mbilal1857@gmail.com03440846288

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026